We are live on ! Find out more
SIOX

Sio Gene Therapies Inc. Common Stock
SIOX

Delisted

SIOX was delisted on the 22nd of March, 2023.

Back to rankings

52 hedge funds and large institutions have $1.99B invested in Sio Gene Therapies Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 52 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
+52
Holders Change %
–
% of All Funds
1.4%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.11%
New
52
Increased
–
Reduced
–
Closed
–
Calls
$212K
Puts
–
Net Calls
+$212K
Net Calls Change
+$212K

Top Buyers

Rank Fund Capital Flow
1
QF
QVT Financial
New York
+$1.59B
2
VAM
Visium Asset Management
New York
+$108M
3
RCM
RA Capital Management
Massachusetts
+$106M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$37.1M
5
Franklin Resources
Franklin Resources
California
+$36.5M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
LCM
26
Laurion Capital Management
New York
$1.83M +$1.91M +11,250 New
ACM
27
Atika Capital Management
New York
$1.53M +$1.59M +9,375 New
Millennium Management
28
Millennium Management
New York
$1.52M +$1.58M +9,322 New
FCMI
29
Foresite Capital Management II
California
$1.32M +$1.38M +8,125 New
Tudor Investment Corp
30
Tudor Investment Corp
Connecticut
$937K +$975K +5,750 New
BlackRock
31
BlackRock
New York
$834K +$867K +5,113 New
MCM
32
Moore Capital Management
New York
$815K +$847K +5,000 New
Citadel Advisors
33
Citadel Advisors
Florida
$691K +$718K +4,234 New
OAC
34
OMERS Administration Corp
Ontario, Canada
$691K +$718K +4,238 New
PIM
35
Partner Investment Management
California
$464K +$482K +2,846 New
HCMT
36
Highland Capital Management (Texas)
Texas
$408K +$424K +2,500 New
Hudson Bay Capital Management
37
Hudson Bay Capital Management
Connecticut
$408K +$424K +2,500 New
SCM
38
Sterling Capital Management
North Carolina
$408K +$424K +2,500 New
PCA
39
Private Capital Advisors
Connecticut
$346K +$360K +2,125 New
BIM
40
BlackRock Investment Management
Delaware
$306K +$318K +1,875 New
PCM
41
Pentwater Capital Management
Florida
$306K +$318K +1,875 New
SG Americas Securities
42
SG Americas Securities
New York
$295K +$307K +1,811 New
LCM
43
Landscape Capital Management
New Jersey
$206K +$214K +1,263 New
ACH
44
ArrowMark Colorado Holdings
Colorado
$204K +$212K +1,250 New
Norges Bank
45
Norges Bank
Norway
$102K +$106K +625 New
MCM
46
Mazama Capital Management
Oregon
$51K +$53.2K +314 New
GGHC
47
Gilder Gagnon Howe & Co
New York
$20K +$21.2K +125 New
AIG
48
American International Group
New York
$10.2K +$10.7K +63 New
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
$10K +$10.7K +63 New
TRCT
50
Tower Research Capital (TRC)
New York
$10K +$10.8K +64 New
1
2
3

SIOX Hedge Fund Activity: Q2 2015 in Review

52 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Sio Gene Therapies Inc. Common Stock (SIOX) for Q2 2015, worth a combined $1.99B.

Buyers outnumbered sellers: 52 funds opened new SIOX positions and 0 closed out — a net gain of 52 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was QVT Financial, opening a new position worth an estimated $1.59B.

  • 52 institutional investors held Sio Gene Therapies Inc. Common Stock (SIOX) as of Q2 2015, up from 0 in Q1 2015.
  • Funds reported $1.99B of Sio Gene Therapies Inc. Common Stock stock for Q2 2015.
  • 52 funds opened new Sio Gene Therapies Inc. Common Stock positions in Q2 2015 and 0 closed out, a net change of +52 holders.
  • The largest Sio Gene Therapies Inc. Common Stock buyer in Q2 2015 was QVT Financial, an estimated $1.59B added.

Based on aggregated 13F filings for Q2 2015.